German Biotech Biz Aims For €132.7M Valuation In IPO
German biotech company Pentixapharm said Monday that it is set to launch an initial public offering valued at approximately €23.4 million ($26 million) on the Frankfurt stock exchange on Tuesday at...To view the full article, register now.
Already a subscriber? Click here to view full article